Vor Biopharma Inc.
VORNasdaqCIK 1817229HealthcareFiscal year ends Dec 31
Reports and events: 114 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3008:01 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001193125-26-439905 |
| 2026-08-1109:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-343607 |
| 2026-07-2116:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000197 |
| 2026-07-0716:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-297454 |
| 2026-06-1216:11 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-269431 |
| 2026-06-0816:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-261661 |
| 2026-05-1308:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-220689 |
| 2026-04-2716:00 ET | DEF 14A | Proxy statementPeriod 2026-04-23 | 0001193125-26-181883 |
| 2026-04-2119:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000113 |
| 2026-04-1517:31 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000107 |
| 2026-04-1018:25 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000103 |
| 2026-04-0818:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000101 |
| 2026-04-0117:09 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000090 |
| 2026-03-3008:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-130451 |
| 2026-03-2708:03 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-127609 |
| 2026-03-1616:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-028470 |
| 2026-01-1209:55 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009961 |
| 2026-01-0216:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-000905 |
| 2025-12-2316:05 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-25-330843 |
| 2025-12-1818:31 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-25-000081 |
| 2025-12-1816:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-324768 |
| 2025-12-0907:58 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-311957 |
| 2025-11-1418:13 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-25-000059 |
| 2025-11-1316:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-280104 |
| 2025-11-1207:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-275862 |
| 2025-11-0308:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-261723 |
| 2025-10-3018:42 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-25-000033 |
| 2025-10-2816:37 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-253636 |
| 2025-10-2720:06 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-25-000029 |
| 2025-10-2018:58 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-25-000022 |
| 2025-10-1718:36 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0002050755-25-000018 |
| 2025-10-1616:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0002050755-25-000016 |
| 2025-10-1017:52 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0002050755-25-000014 |
| 2025-10-0817:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0002050755-25-000012 |
| 2025-10-0617:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0002050755-25-000010 |
| 2025-09-1916:53 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-25-000007 |
| 2025-09-1709:00 ET | 8-K | 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-205553 |
| 2025-09-1219:07 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-024456 |
| 2025-09-0918:04 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-023998 |
| 2025-09-0210:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-193600 |
| 2025-08-2918:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-023320 |
| 2025-08-2712:34 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-189435 |
| 2025-08-2708:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-189169 |
| 2025-08-1216:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-107276 |
| 2025-08-0808:55 ET | DEF 14A | Proxy statementPeriod 2025-08-25 | 0001140361-25-029749 |
| 2025-07-2217:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-162644 |
| 2025-07-1016:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-157638 |
| 2025-07-0917:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-019583 |
| 2025-06-2716:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-018378 |
| 2025-06-2621:18 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-147339 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 31, 2026, 03:06 ET. Listed shows no prices and gives no investment advice.